Tetracyclines and Chemically Modified Tetracycline-3 (CMT-3) Modulate Cytokine Secretion by Lipopolysaccharide-Stimulated Whole Blood
Authors:
- 24 February 2009
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 32 (2) , 130-137
Abstract
In addition to their bacteriostatic effect, tetracyclines, which are often used in the treatment of periodontitis, also present anti-inflammatory properties. In the present study, we investigated the effects of tetracycline (TC), doxycycline (doxy), and chemically modified tetracycline-3 (CMT-3) on the production of pro-inflammatory mediators and matrix metalloproteinases (MMPs) in an ex vivo human whole blood (WB) model stimulated with Porphyromonas gingivalis lipopolysaccharide (LPS). WB samples obtained from three periodontitis patients and six healthy subjects were stimulated with P. gingivalis LPS in the absence and presence of TC, doxy, or CMT-3. The secretion of interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), MMP-8, and MMP-9 by the WB samples was determined using enzyme-linked immunosorbent assays. P. gingivalis LPS significantly increased the secretion of all cytokines and MMPs tested. While we observed inter-patient variations, TC, doxy, and CMT-3 caused reductions of LPS-induced cytokine secretion to various degrees. TC, doxy, and CMT-3 had no significant effect on MMP-8 and MMP-9 secretion by LPS-stimulated WB samples. In conclusion, we used a human WB model that takes into consideration relevant in vivo immune cell interactions in the presence of plasma proteins to show that TC, doxy, and CMT-3 can reduce the production of pro-inflammatory mediators. This property may contribute to the clinically proven benefits of these molecules in the treatment of periodontitis and other chronic inflammatory diseases.Keywords
This publication has 35 references indexed in Scilit:
- Doxycycline Reduces Lipopolysaccharide‐Induced Inflammatory Mediator Secretion in Macrophage and Ex Vivo Human Whole Blood ModelsJournal of Periodontology, 2008
- Actinobacillus actinomycetemcomitans lipopolysaccharide regulates matrix metalloproteinase, tissue inhibitors of matrix metalloproteinase, and plasminogen activator production by human gingival fibroblasts: A potential role in connective tissue destructionJournal of Cellular Physiology, 2007
- Cranberry components inhibit interleukin‐6, interleukin‐8, and prostaglandin E2 production by lipopolysaccharide‐activated gingival fibroblastsEuropean Journal of Oral Sciences, 2007
- Tetracyclines: Nonantibiotic properties and their clinical implicationsJournal of the American Academy of Dermatology, 2006
- The Contribution of Interleukin‐1 and Tumor Necrosis Factor to Periodontal Tissue DestructionJournal of Periodontology, 2003
- Relationship of changes in interleukin‐8 levels and granulocyte elastase activity in gingival crevicular fluid to subgingival periodontopathogens followingnon‐surgical periodontal therapy in subjects with chronic periodontitisJournal of Clinical Periodontology, 2002
- Long‐Term Use of Subantimicrobial Dose Doxycycline Does Not Lead to Changes in Antimicrobial SusceptibilityJournal of Periodontology, 2000
- Concentration of 3 tetracyclines in plasma, gingival crevice fluid and salivaJournal of Clinical Periodontology, 2000
- Tetracyclines in the management of periodontal diseasesJournal of Clinical Periodontology, 1995
- Suppression of human neutrophil functions by tetracyclinesJournal of Periodontal Research, 1991